Avidian Technologies, developers of the award-winning Prophet CRM software for Outlook, announced that over 30,000 licenses of Prophet 4.0 have now been sold worldwide. This latest announcement comes as yet another milestone for Prophet, a leading Outlook-based CRM software for small businesses.
"This is a clear indication of Avidian's continued growth and Prophet's increasing share of the small business CRM software market," said Tim Nguyen, CTO and co-founder of Avidian. "Prophet 4.0 software has been given a four-star rating by PC World magazine as well as numerous other awards. Customers and media continue to be impressed by its functionality, ease of use and deep integration within Outlook. These factors combine to make Prophet a popular choice for small businesses looking for CRM software that works with Outlook."
Avidian's Prophet software includes many essential contact management and sales automation features and tools, allowing sales managers in businesses of all sizes to easily keep track of sales prospects from initial contact to closing. The software also provides fully-automated reporting that can be accessed instantly.
Prophet is designed for use with Microsoft Outlook and can be installed quickly and used almost immediately. It offers great flexibility, as it operates on desktops, laptops, Pocket PCs, Windows Mobile and Palm devices.
The fact that over 30,000 licenses have been sold worldwide is a clear indication that Avidian is setting the standard in the industry and will continue to grow. In addition, the company continues to work on developing innovations and improvements for its product line that will further enhance sales of its software.
About Avidian
Avidian Technologies is a software company specializing in creating software solutions for users of Outlook and Exchange. Prophet, developed by Avidian Technologies on the .NET platform, is the leading sales CRM software in Microsoft Outlook. The company is headquartered in Redmond, Washington. For more information, please visit www.avidian.com.